CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
Clinical trials for CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) trials appear
Sign up with your email to follow new studies for CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Hard-to-Treat leukemias: first human trial begins
Disease control Recruiting nowThis early-stage study tests a new drug called STX-0712 in people with advanced types of leukemia (CMML or AML) that have not responded to other treatments. The main goals are to find a safe dose and check for side effects. About 105 adults will take part in this first-in-human t…
Matched conditions: CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
Phase: PHASE1 • Sponsor: Solu Therapeutics, Inc • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New combo therapy aims to tame rare blood cancers
Disease control Recruiting nowThis study tests a new drug, axatilimab, alone and with the standard drug ruxolitinib, in people with myelofibrosis (MF) or chronic myelomonocytic leukemia (CMML). The goal is to find a safe dose and see if the combination helps control the disease. About 66 adults who have alrea…
Matched conditions: CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
New hope for tough blood cancers: CBX-250 trial opens
Disease control Recruiting nowThis early-stage study tests a new drug called CBX-250 in about 72 people with certain blood cancers (like acute myeloid leukemia) that have returned or not improved with standard therapy. The main goals are to check the drug's safety and find the best dose. Participants receive …
Matched conditions: CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
Phase: PHASE1 • Sponsor: Crossbow Therapeutics, Inc. • Aim: Disease control
Last updated May 11, 2026 20:47 UTC
-
New drug cocktails aim to tame transplant complications in blood cancer patients
Disease control Recruiting nowThis study tests new drug combinations to prevent graft-versus-host disease (GVHD) in people with blood cancers who receive stem cells from an unrelated donor. About 358 participants will get either the standard GVHD prevention drugs or a new mix, and researchers will compare whi…
Matched conditions: CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
Phase: PHASE2 • Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Disease control
Last updated May 11, 2026 20:41 UTC